News

Introduces new platform which will reduce human error and accelerate trials.

EMA reminds the clinical trials community that the Clinical Trials Information System will be mandatory at the last day of this month.

National site network continues expansion, partners with Moderna on CMVictory Trial.

Strategic acquisition enables Tigermed to enhance its services in Europe.

The latest business and people happenings of the last month, all in one place.

THREAD will serve as the sole provider of DCTs and eCOA technology under new five-year collaboration.

New patient-reported outcome measure developed in collaboration with The Epilepsy Study Consortium.

Renewed interest in psychedelic research shows great promise for patients in need of more effective therapies.

New public benefit corporation seeks to unlock access to traditionally siloed data through RWD platform.

Study in collaboration with the Medical Research Council Epidemiology Unit at the University of Cambridge showed participants had high levels of engagement in remote COVID-19 study.

Market size expected to reach $1.96 million by 2030.

New South Korea office location part of APAC expansion plan for 2023.

Analysis shows breast cancer was the most extensively studied disease area in previous year.

Expands drug development and FDA regulatory expertise.

Deal takes the Phastar group to around 550 people worldwide and strengthens the company's position in Nordic region.

Combined Pinnacle and STRI platform expands network to six stand-alone sites.

Collaboration will aim to improve patient identification, stratification, recruitment, and enrollment in rare disease trials.

Company provides startup biotechs access to collaboration platform for a year.

Transaction gives NEUCA Group a 72.6% stake in OncoBay.

Partnership aims to accelerate discovery of treatments for rare diseases.

Study finds that digital maturity, capability prioritization, and best practice adoption vary widely.

The financial transaction details pertaining to the eClinical technology provider's deal were not disclosed.

The latest industry happenings, all in one place.

New collaboration leverages MyEyeDr.’s offices across the US to refer patients into ophthalmology and other therapeutic area clinical trials, expands Parexel’s Community Alliance Network to bring trials to patients where they are.

Strong shift to DCTs, regulatory changes, and increased focus on diversity among main industry talking points in 2022.

Targeted program aims to identify and accelerate novel oncology innovations into commercially-attractive assets.

Kenneth Koblan, PhD, chief scientific officer at Sunovion, discusses novel therapy development and clinical trial challenges in mental health.

Partnership will allow providers to recommend clinical trials as a therapeutic option at the point-of-care using IllumiCare's Trials App.